Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Invested Capital: 2018-2019

Historic Invested Capital for DiaMedica Therapeutics (DMAC) over the last 2 years, with Sep 2019 value amounting to $9.7 million.

  • DiaMedica Therapeutics' Invested Capital rose 136.01% to $9.7 million in Q3 2019 from the same period last year, while for Sep 2019 it was $9.7 million, marking a year-over-year increase of 136.01%. This contributed to the annual value of $17.0 million for FY2018, which is N/A change from last year.
  • As of Q3 2019, DiaMedica Therapeutics' Invested Capital stood at $9.7 million, which was down 17.11% from $11.7 million recorded in Q2 2019.
  • Over the past 5 years, DiaMedica Therapeutics' Invested Capital peaked at $17.0 million during Q4 2018, and registered a low of $4.1 million during Q3 2018.
  • Its 2-year average for Invested Capital is $9.8 million, with a median of $9.7 million in 2019.
  • Data for DiaMedica Therapeutics' Invested Capital shows a peak YoY surged of 136.01% (in 2019) over the last 5 years.
  • Over the past 2 years, DiaMedica Therapeutics' Invested Capital (Quarterly) stood at $17.0 million in 2018, then skyrocketed by 136.01% to $9.7 million in 2019.
  • Its last three reported values are $9.7 million in Q3 2019, $11.7 million for Q2 2019, and $13.9 million during Q1 2019.